4//SEC Filing
Stancic Ana 4
Accession 0000930413-11-007514
CIK 0000727510other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:00 PM ET
Size
8.4 KB
Accession
0000930413-11-007514
Insider Transaction Report
Form 4
Stancic Ana
Senior VP, Finance and CFO
Transactions
- Award
Common Stock
2011-11-17+45,000→ 70,000 total - Award
Employee Stock Option (Right to Buy)
2011-11-17+125,000→ 155,000 totalExercise: $6.37Exp: 2011-11-17→ Common Stock (125,000 underlying)
Footnotes (4)
- [F1]Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The Restricted Stock Units shall vest in full on November 17, 2014, if the Reporting Person remains employed by the Issuer on such date, and do not have an expiration date; provided, however, that the vesting of 50% of the Restricted Stock Units shall be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer.
- [F3]Options granted by Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d).
- [F4]The options will vest in four (4) tranches. Of the 125,000 options granted, 31,250 options will vest on November 17, 2012, 31,250 options will vest on November 17, 2013, 31,250 options will vest on November 17, 2014, and the remaining 31,250 options will vest on November 17, 2015 if the Reporting Person remains employed by the Issuer on each such date.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001320271
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:00 PM ET
- Size
- 8.4 KB